Navigation Links
Anadys Highlights ANA773 Data to be Presented at ASCO
Date:5/25/2011

advanced solid tumors were treated with ANA773 every-other-day (QOD) for 14 days, followed by a 14 day rest period, on continuous 28 day cycles.  20 patients participated in the study and were treated at dose levels of either 50mg, 100mg, 200mg, 400mg or 800mg (all QOD), with a minimum of three patients enrolled at each dose level. The endpoints for the study included safety, pharmacokinetics, biomarkers of immune activation and preliminary assessment of tumor response by RECIST.  

Next Steps for ANA773 Development

Anadys is advancing development of ANA773 in a separate indication, chronic hepatitis C virus infection, or HCV.  Anadys is currently preparing for a Phase IIa study of ANA773 in combination with ribavirin in HCV patients, which it expects to initiate in Europe this quarter.  The Company expects to receive 28-day data from the Phase IIa HCV study during the fourth quarter of this year.

About TLR7 agonists in cancer therapy

The potential benefits of the TLR7 mechanism in cancer therapy arise from the fundamental role of this receptor in immune activation.  The host immune system, once activated, plays an essential role in controlling the ability of cancer cells to grow, invade and metastasize.  Immunotherapy has had some success in treating selected tumors, and the potential to harness the immune system as a therapeutic modality remains of great interest to many oncologists.

TLR7 agonists are of particular interest because there is precedent for their use in cancer. Small molecule ligands for this receptor have been identified, including topical imiquimod (Aldara®) which is approved for the treatment of basal cell carcinoma in the United States. Imiquimod and other TLR7 agonists have also demonstrated early clinical activity against other tumor types, including melanoma and chronic lymphocytic leukemia. 

About Anadys

Anadys
'/>"/>

SOURCE Anadys Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Anadys Pharmaceuticals to Report Third Quarter 2008 Financial Results
2. Anadys Pharmaceuticals to Present at BIOCOM Investor Conference 2008
3. Anadys Pharmaceuticals Reports Third Quarter 2008 Financial Results and Highlights
4. Anadys Pharmaceuticals Commences Dosing ANA773 in Hepatitis C Patients
5. Anadys Pharmaceuticals to Present at Rodman & Renshaw Annual Global Investment Conference
6. Anadys Pharmaceuticals to Present at the Needham Focus on Infectious Disease Conference
7. Anadys Pharmaceuticals to Present at the Piper Jaffray Health Care Conference
8. Anadys Pharmaceuticals to Present at Future Leaders in the Biotech Industry
9. Anadys Pharmaceuticals to Report First Quarter 2009 Financial Results
10. Anadys Pharmaceuticals Reports First Quarter 2009 Financial Results and Highlights
11. Anadys Pharmaceuticals, Inc. Announces Strategic Restructuring to Focus Operations on Continuing the Advancement of ANA598
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/1/2014)... 2014 The participants committed to not ... spending their own time adjusting, tweaking and testing virtual ... were ready for judging. , “I enjoyed being involved ... leader. “The entries showed a commendable range exploring ... of the print medium and the creativity of the ...
(Date:10/1/2014)... October 01, 2014 Slone Partners ... Therapeutics, Healthcare IT, and Laboratory Testing industries, reported a ... at the director level and above from July 2013 ... stay on top of rapid breakthroughs in diagnostics, reimbursement ... diagnostic companies have been forced to fold, consolidate, or ...
(Date:9/30/2014)... is available in German . ... several quantum dots in a semiconductor layer. Quantum dots are ... atomic processes. If a short laser pulse is fired at ... quantum dot experiences a change in the electromagnetic field around ... emission of light by the dot. As soon as the ...
(Date:9/30/2014)... YORK , Sept. 30, 2014 ... and segments with highest potential revenues Do you ... updated report gives you revenue predictions for those ... For those therapies you find financial data, R&D ... analysis you get sales forecasts to 2024 at ...
Breaking Biology Technology:Array Architects Challenges Staff to Create with 3D Printer 2Slone Partners Meets Growing Demand as Industry Focuses on Reimbursement & Regulation 2Ultrafast remote switching of light emission 2Biosimilars and Follow-On Biologics: World Industry and Market Prospects 2014-2024 2Biosimilars and Follow-On Biologics: World Industry and Market Prospects 2014-2024 3Biosimilars and Follow-On Biologics: World Industry and Market Prospects 2014-2024 4Biosimilars and Follow-On Biologics: World Industry and Market Prospects 2014-2024 5
... Much of Thursday's Digital Healthcare Conference ... facing plenty of them. , ,In today's issue, the ... from the Digital Healthcare Conference, you'll read about the ... are approaching those choices. Next issue, look for coverage ...
... to the north. The country brings to mind Mounties and ... Vancouver, British Columbia supports a thriving technology development environment, and ... a week there recently, meeting with some very savvy developers. ... some of the companies I met there. , , Imagis ...
... Brookfield-based Fiserv, Inc. , has ... management and billing software for large and mid-sized ... ,Interactive Technologies, headquartered in Summit, New Jersy, develops ... management companies, depositories, exchanges and other high-end providers ...
Cached Biology Technology:The tough choices facing health care 2The tough choices facing health care 3Imagis emerges from bumpy road 2Imagis emerges from bumpy road 3
(Date:9/30/2014)... Mediterranean each year, but its deep-blue waters host ... 1,000 alien species, including fish, crustaceans, and algae ... activities. In the open-access journal Frontiers in ... analyzed data from a new information system developed ... introduction of alien species has changed the native ...
(Date:9/30/2014)... Engineers at the University of California, San Diego, have ... tissue using a method that uses the pixels in ... method known as mesh-free simulation. , The researchers, led ... engineering at the Jacobs School of Engineering at UC ... this method at the CompIMAGE,14 conference in Pittsburgh this ...
(Date:9/30/2014)... assessment conducted by the Ocean Health Index rates ... in overall health. In addition, for the first ... 15 ocean regions beyond national jurisdiction (high-seas areas) ... climate, safeguarding biodiversity and providing sustainable food sources. ... index, a partnership led by scientists from UC ...
Breaking Biology News(10 mins):Biodiversity in the Mediterranean is threatened by alien species 2First comprehensive meshfree numerical simulation of skeletal muscle tissue achieved 2Rating the planet's oceans 2Rating the planet's oceans 3
... painful relationship with Campylobacter jejuni, we are just starting ... the leading cause of bacterial food-borne illness in the ... of diarrhea worldwide. The Centers for Disease Control estimate ... , While most sufferers recover after a few unpleasant ...
... University in Ithaca and Weill Cornell Medical College in ... protein biomarkers in cerebrospinal fluid that acts as a ... patients living with Alzheimer's disease. , The research will ... Annals of Neurology. , Right now, physicians ...
... 2006 -- A new study in Journal of the World ... smaller shrimp of the same gender when competing for food, ... adult males of the species are typically much smaller than ... and gender are important factors in acquiring food," says study ...
Cached Biology News:The biggest bug in gut discomfort 2Protein 'fingerprint' in spinal fluid could spot Alzheimer's disease 2Protein 'fingerprint' in spinal fluid could spot Alzheimer's disease 3
... Terminal deoxynucleotidyl transferase (TdT) is an ... in cortical thymocytes and minor subpopulation of ... enzyme and increased numbers of TdT cells ... lymphoblastic leukaemias and lymphomas. Presence of TdT ...
Request Info...
... The RapidStak is a fast ... its class. Its high capacity ... and more confident walk away time ... and ease of set-up make for ...
... to MLF1 Interacting Protein/PBIP1 (phospho T78) ... applications). Antigen: ... acids 73-83 of Human MLF1 Interacting ... ID: 359815 ...
Biology Products: